NFKB1 and neoplasm: Treatment with NAC also reportedly hinders the effects of certain chemotherapeutic drugs, such as paclitaxel, by decreasing ROS levels to the extent that apoptosis of tumor cells is prevented [8], and alters the response of the redox-sensitive NF-κB signal transduction pathway in tumor cells targeted by doxorubicin-induced ROS [54].